Since 2024: Research Associate, Quantitative Health Services Research Group, Institute of General Medicine, Jena University Hospital

2021 – 2023: Research Associate / Study Physician, Department of Neurology, Leipzig University Hospital

2018 – 2019: Student Assistant, Institute of Neuropathology, Leipzig University Hospital

Since 2019: Studies in Bioinformatics, Faculty of Mathematics and Computer Science, Leipzig University

2013 – 2020: Studies in Human Medicine, Faculty of Medicine, Leipzig University and Oxford Medical School, University of Oxford, United Kingdom

Schmidt R, Slotina E, Meissner F, Metelmann M, Ilse B, Vogt V, Freytag A. Palliative care pathways in Amyotrophic Lateral Sclerosis (ALS): a sequence analysis of health claims data. BMC Palliative Care. 2025 Jul 14;24(1):200.

Schmidt R, Huber C, Pelz JO, Classen J, Michalski D. Trends in acute care of cerebrovascular events- a joinpoint analysis with German hospital data from 2000 to 2021. Neurological Research and Practice. 2025 Jun 27;7(1):46.

Schmidt R, Starke A, Bednarz N, Then Bergh F. Effect of impairment on health-related quality of life in people with multiple sclerosis: association of functional systems and EQ-5D-5L index values in a cross-sectional study. Quality of Life Research. 2025 Mar 6.

Michalski D, Classen J, Geisler D, Urban D, Schreiber M, Tylcz JB, Schmidt R, Prost A, Handel T, Schneider A, Lippmann S, Bleckwenn M, Ivanova G. First experience in employing a complex digital support system accompanied by personal assistance to improve aftercare in patients with stroke or transient ischemic attack - results of the PostStroke-Manager feasibility study. Scientific Reports. 2025 Feb 17;15(1):5804.

Huber C, Stöbe S, Hagendorff A, Mühlberg KS, Hoffmann KT, Isermann B, Wachter R, von Dercks N, Schmidt R, Pelz JO, Michalski D. Deep vein thrombosis in patients with stroke or transient ischemic attack presenting with patent foramen ovale: a retrospective observational study. BMC Neurology. 2024 Aug 26;24(1):295.

Schmidt R, Geisler D, Urban D, Pries R, Franzisket C, Voigt C, Ivanova G, Neumuth T, Classen J, Wagner M, Michalski D. Stroke survivors' preferences on assessing patient-reported outcome measures. Journal of Patient-Reported Outcomes. 2023 Nov 30;7(1):124.

Schmidt R, Geisler D, Urban D, Wagner M, Ivanova G, Neumuth T, Classen J, Michalski D. Topics Mentioned by Stroke Patients during Supportive Phone Calls-Implications for Individualized Aftercare Programs. Healthcare (Basel). 2022 Nov 29;10(12):2394.

Schmidt R, Vogt V, Freytag A. Sequence-based cluster analysis of care pathways using the example of palliative care for people with Amyotrophic Lateral Sclerosis (ALS) [Sequenzbasierte Clusteranalyse von Versorgungspfaden am Beispiel Palliativmedizinischer Versorgung von Menschen mit Amyotropher Lateralsklerose (ALS)] (Presentation). German Congress for Health Services Research (DKVF) 2025; Hamburg.

Schmidt R, Slotina E, Meissner F, Metelmann M, Ilse B, Vogt V, Freytag A. Palliative care pathways in ALS: Results of a statutory health insurance routine data analysis [Palliativmedizinische Versorgungspfade bei ALS: Ergebnisse einer GKV-Routinedaten-Analyse] (Presentation). Neuro-Palliative Care Spring Symposium 2025; Jena.

Schmidt R, Vogt V, Freytag A. Palliative care pathways in ALS: A sequence-based cluster analysis of statutory health insurance routine data [Palliativmedizinische Versorgungspfade bei ALS: Eine sequenzbasierte Clusteranalyse von GKV-Routinedaten] (Presentation). Working Group for Secondary Data Collection and Utilization – Methods Workshop 2024; Mar 6–Mar 7, 2025; Jena.

Schmidt R, Vogt V, Michalski D. Temporal trends in inpatient treatment rates for ischemic stroke and transient ischemic attack from 2006 to 2021 [Zeitliche Entwicklung stationärer Behandlungsraten des ischämischen Schlaganfalls und der transitorisch ischämischen Attacke von 2006 bis 2021] (Poster). 97th Congress of the German Society of Neurology; Nov 6–Nov 9, 2024; Berlin.

Schmidt R, Michalski D, Vogt V. Comparison of hospital length of stay and corresponding influencing factors in ischemic stroke and transient ischemic attack [Vergleich von Krankenhausverweildauer und korrespondierenden Einflussfaktoren bei ischämischem Schlaganfall und transitorisch-ischämischer Attacke] (Poster). 23rd German Congress for Health Services Research (DKVF); Sep 25–Sep 27, 2024; Potsdam.

Schmidt R, Claßen J, Michalski D. Age, period, and cohort effects in the incidence analysis of ischemic stroke in Germany [Alters-, Perioden- und Kohorteneffekte in der Inzidenzbetrachtung des ischämischen Schlaganfalls in Deutschland] (Poster). 96th Congress of the German Society of Neurology; Nov 8–Nov 10, 2023; Berlin.

Schmidt R, Then Bergh F. Age-, period- and cohort-specific trends in inpatient treatment of multiple sclerosis (Poster). MSMilan2023 – 9th Joint ECTRIMS-ACTRIMS Meeting; Oct 11–Oct 13, 2023; Milan.

Schmidt R, Wagner M, Claßen J, Michalski D. Evidence of digital applications in stroke aftercare – an overview [Evidenz digitaler Anwendungen in der Schlaganfallnachsorge – eine Übersicht] (Poster). 95th Congress of the German Society of Neurology; Nov 1–Nov 5, 2022; Berlin.

Schmidt R, Haars S, Unterlauft A, Jamra R, Then Bergh F. Screening for differential diagnoses in multiple sclerosis: evaluation of inclusion criteria for extensive diagnostic workup (Poster). 74th AAN Annual Meeting; Apr 2–Apr 7, 2022; Seattle.

Schmidt R, Haars S, Then Bergh F. Screening for differential diagnoses in MS: Evaluation of inclusion criteria for extensive diagnostic workup (Poster). 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; Sep 11–Sep 13, 2019; Stockholm.

Rullmann M, Haars S, Werner P, Schmidt R, Orthgieß J, Tiepolt S, Patt M, Lobsien D, Hoffmann K-T, Sabri O, Barthel H, Then Bergh F. [18F]-Florbetaben PET/MRI as a myelin-specific marker in various white matter diseases – a pilot study [[18F]-Florbetaben-PET/MRT als Myelin-spezifischer Marker bei verschiedenen Erkrankungen der weißen Substanz – eine Pilotstudie] (Presentation). 56th Annual Meeting of the German Society of Nuclear Medicine; Apr 18–Apr 21, 2018; Bremen.

Haars S, Werner P, Schmidt R, Rullmann M, Orthgieß J, Tiepolt S, Patt M, Lobsien D, Hoffmann K-T, Sabri O, Then Bergh F, Barthel H. [18F]-Florbetaben-PET/MRI as myelin-specific molecular imaging: a pilot study in patients with different white matter diseases (Poster). ECTRIMS/ACTRIMS Joint Congress 2017; Oct 25–Oct 28, 2017; Paris.

Rullmann M, Haars S, Werner P, Schmidt R, Orthgieß J, Tiepolt S, Patt M, Lobsien D, Hoffmann K-T, Sabri O, Barthel H, Then Bergh F. A Pilot Study on Hybrid 18F-Florbetaben PET/MRI in Patients with White Matter Diseases (Presentation). Annual Congress of the European Association of Nuclear Medicine; Oct 21–Oct 25, 2017; Vienna.

Haars S, Schmidt R, Orthgieß J, Stoppe M, Then Bergh F. Alterations of serum lipid profile in multiple sclerosis patients treated with fingolimod (Poster). 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis; Sep 14–Sep 17, 2016; London.